Work

Sécurité et efficacité à long terme de l’ofatumumab chez les personnes atteintes de sclérose en plaques récurrente pour une durée allant jusqu’à 6 ans

Year: 2025

Type: article

Source: Revue Neurologique

DOI: 10.1016/j.neurol.2025.01.264

Authors: Jérôme De Sèze, Heinz Wiendl, Stephen L. Hauser, Jacqueline Nicholas, Ibolya Boer, Jeffrey A. Cohen, Ludwig Kappos

Institutions: Hôpitaux Universitaires de Strasbourg, University Medical Center Freiburg, University of California, San Francisco, OhioHealth, Riverside Methodist Hospital, Novartis (Switzerland), Cleveland Clinic, University of Basel, University Hospital of Basel

Language: French

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408567982

FWCI:

Cites:

Cited by:

Related to: 10